AA
Addison Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $878K | Buy |
4,729
+60
| +1% | +$11.1K | 0.22% | 83 |
|
|
2025
Q1 | $978K | Sell |
4,669
-10
| -0.2% | -$2.1K | 0.27% | 66 |
|
|
2024
Q4 | $831K | Sell |
4,679
-113
| -2% | -$20.1K | 0.23% | 74 |
|
|
2024
Q3 | $946K | Sell |
4,792
-302
| -6% | -$59.6K | 0.26% | 68 |
|
|
2024
Q2 | $874K | Buy |
5,094
+146
| +3% | +$25K | 0.28% | 67 |
|
|
2024
Q1 | $901K | Buy |
4,948
+429
| +9% | +$78.1K | 0.31% | 67 |
|
|
2023
Q4 | $700K | Sell |
4,519
-109
| -2% | -$16.9K | 0.27% | 70 |
|
|
2023
Q3 | $690K | Buy |
4,628
+170
| +4% | +$25.3K | 0.32% | 65 |
|
|
2023
Q2 | $601K | Sell |
4,458
-11
| -0.2% | -$1.48K | 0.3% | 68 |
|
|
2023
Q1 | $712K | Buy |
4,469
+227
| +5% | +$36.2K | 0.4% | 56 |
|
|
2022
Q4 | $686K | Sell |
4,242
-241
| -5% | -$38.9K | 0.41% | 52 |
|
|
2022
Q3 | $602K | Sell |
4,483
-4
| -0.1% | -$537 | 0.37% | 55 |
|
|
2022
Q2 | $687K | Sell |
4,487
-46
| -1% | -$7.04K | 0.42% | 52 |
|
|
2022
Q1 | $735K | Buy |
4,533
+1,372
| +43% | +$222K | 0.4% | 57 |
|
|
2021
Q4 | $428K | Buy |
3,161
+705
| +29% | +$95.5K | 0.26% | 73 |
|
|
2021
Q3 | $265K | Buy |
2,456
+6
| +0.2% | +$647 | 0.21% | 64 |
|
|
2021
Q2 | $276K | Buy |
+2,450
| New | +$276K | 0.22% | 63 |
|
|
2020
Q4 | $284K | Buy |
+2,650
| New | +$284K | 0.27% | 60 |
|